BiotechTube
Home/Vera Therapeutics/Marshall Fordyce, MD
MF

Marshall Fordyce, MD

CEO and Founder

Vera Therapeutics

Therapeutic Areas

NephrologyAutoimmune DiseasesInfectious Diseases

Vera Therapeutics Pipeline

DrugIndicationPhase
AtaciceptIgA Nephropathy (IgAN)Phase 2b/3
MAU868BK Virus Viremia in Kidney Transplant PatientsPhase 2

Leadership Team at Vera Therapeutics

RM
Robert M. Brenner, MD
Chief Medical Officer
LF
Lauren Frenz, MBA
Chief Business Officer
View full Vera Therapeutics profile